Most Read Articles
Tristan Manalac, 3 days ago
Of the newly identified genetic loci for primary angle-closure glaucoma (PACG), two are significantly associated with primary angle-closure suspect (PACS), indicating involvement in the earlier stages of the disease, a recent Singapore study has shown.
5 days ago
Use of proton pump inhibitors (PPIs), even at higher cumulative levels, does not increase the risk for dementia, a recent study has shown.
6 days ago
Persons with congenital heart disease (CHD) are at a higher risk of dementia, particularly early-onset dementia, than the general population, a recent study has shown.
Tristan Manalac, 5 days ago
Placebo pills, even when administered open-label, appear to significantly improve cancer-related fatigue and fatigue-disrupted quality of life, according to a recent study.

Adrenalectomy, MRA improve QoL in primary aldosteronism

10 Feb 2018

Both surgical (adrenalectomy) and medical (mineralocorticoid receptor antagonists [MRA]) treatments improve quality of life (QoL) in primary aldosteronism (PA), which highlights the importance of identifying these patients, according to a recent study.

In addition, better improvement in QoL is observed after adrenalectomy for suspected aldosterone-producing adenoma (APA) than after initiation of medical treatment for suspected bilateral adrenal hyperplasia (BAH). APA and BAH are two subtypes of PA.

A total of 184 patients with PA were included in this posthoc comparative effectiveness study within the Subtyping Primary Aldosteronism: A Randomized Trial Comparing Adrenal Vein Sampling and Computed Tomography Scan (SPARTACUS) trial. QoL was assessed at baseline and 6- and 1-year follow-up using two validated questionnaires: RAND 36-item Health Survey (RAND SF-36) and European Quality of Life‒5 Dimensions (EQ-5D).

Patients with PA, compared with the general population, had lower scores in seven of eight RAND SF-36 and both summary scores, as well as in three of five EQ-5D dimensions and the visual analogue scale at baseline.

Adrenalectomy demonstrated larger beneficial effects than those for MRAs for seven RAND SF-36 subscales, both summary scores and health change. For the EQ-5D, there was a difference in favour of adrenalectomy in two dimensions and the visual analogue scale.

In both surgical and medical treatments, most differences in QoL exceeded the minimally clinically important difference. After 1 year, almost all QoL measures had normalized for patients who underwent adrenalectomy. For those on MRAs, most QoL measures had improved but not all to the level of the general population.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Tristan Manalac, 3 days ago
Of the newly identified genetic loci for primary angle-closure glaucoma (PACG), two are significantly associated with primary angle-closure suspect (PACS), indicating involvement in the earlier stages of the disease, a recent Singapore study has shown.
5 days ago
Use of proton pump inhibitors (PPIs), even at higher cumulative levels, does not increase the risk for dementia, a recent study has shown.
6 days ago
Persons with congenital heart disease (CHD) are at a higher risk of dementia, particularly early-onset dementia, than the general population, a recent study has shown.
Tristan Manalac, 5 days ago
Placebo pills, even when administered open-label, appear to significantly improve cancer-related fatigue and fatigue-disrupted quality of life, according to a recent study.